Back to News
Market Impact: 0.12
CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
Source: businesswire.com
Healthcare & Biotech
CEL-SCI has been invited to deliver a keynote address on its Multikine cancer immunotherapy at the 6th World Congress on Otology, Rhinology and Laryngology. The announcement provides external visibility for Multikine but contains no clinical-trial results, regulatory updates, financial figures, or commercial milestones.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
CVM0.35
More News
- Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
- Beta Bionics prices $150M public offering at $17.25/share
- Inside South Korea’s university programs offering a direct route to Samsung and SK Hynix
- A sharp stock market decline could lie around the corner, Wells Fargo warns
- Why is Vera Therapeutics stock reversing its premarket gains?
- H.C. Wainwright raises Scholar Rock stock price target on FDA approval